RTW Investments, LP 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 06:42 am Sale |
2024-09-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW Investments, LP | 1,968,002 2.100% |
-4,919,084 (-71.42%) |
Filing |
| 2024-02-14 07:46 am Purchase |
2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW Investments, LP | 6,887,086 8.400% |
2,920,171 (+73.61%) |
Filing |
| 2023-02-14 10:10 am Purchase |
2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
RTW Investments, LP | 3,966,915 5.700% |
3,966,915 (New Position) |
Filing |